Dean, E., Banerji, U., Schellens, J. H. M., Krebs, M. G., Jimenez, B., van Brummelen, E., . . . Lawrence, P. (2018). A Phase 1, open-label, multicentre study to compare the capsule and tablet formulations of AZD5363 and explore the effect of food on the pharmacokinetic exposure, safety and tolerability of AZD5363 in patients with advanced solid malignancies: OAK. Cancer Chemother Pharmacol.
Citação norma ChicagoDean, Emma, et al. "A Phase 1, Open-label, Multicentre Study to Compare the Capsule and Tablet Formulations of AZD5363 and Explore the Effect of Food On the Pharmacokinetic Exposure, Safety and Tolerability of AZD5363 in Patients With Advanced Solid Malignancies: OAK." Cancer Chemother Pharmacol 2018.
Citação norma MLADean, Emma, et al. "A Phase 1, Open-label, Multicentre Study to Compare the Capsule and Tablet Formulations of AZD5363 and Explore the Effect of Food On the Pharmacokinetic Exposure, Safety and Tolerability of AZD5363 in Patients With Advanced Solid Malignancies: OAK." Cancer Chemother Pharmacol 2018.